Ear Nerve Stimulation Device Tested for Sleep Problems in Childhood Leukemia Survivors
Tests a non-invasive ear device for insomnia in adults who had childhood leukemia.
Key facts
- Who runs it
- St. Jude Children's Research Hospital
- Where
- Memphis, United StatesSee the site
- Trial code
- Registry title
- Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 31 Mar 2026
- Expected to end
- Dec 2029
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Soterix tVNS device
- Soterix tVNS device (sham programmed)
- Sleep Quality
- Neurocognitive and mental health outcomes
- Record updated
- 14 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult survivors of childhood acute lymphoblastic leukemia (ALL) who have moderate to severe insomnia. It tests a small earbud device that gently stimulates a nerve in the ear at night.
- Age
- 20 to 50 years at enrollment, and under 21 years old when the leukemia was diagnosed.
- Sex
- All sexes can join.
- Disease stage
- Survivor of acute lymphoblastic leukemia, enrolled on SJLIFE, with insomnia (Insomnia Severity Index of 8 or more, confirmed before enrollment).
- Earlier treatment
- People currently using a technological sleep treatment such as CPAP cannot join. Sleep medicines and habits like white noise or night-time yoga are fine if the insomnia continues. People taking medicine for neurocognitive impairment or seizures cannot join.
Main reasons for not taking part
- Pregnant or planning to become pregnant
- Implanted electrical medical device, such as a pacemaker
- Seizures in the most recent 1 year
- Certain heart, blood vessel or cranial nerve conditions (CTCAE grade above 2)
- Currently in another neurostimulation or neuromodulation study
The registry criteria, word for word
Show all 28 criteriaShow less
Who can take part
- Survivor of Acute Lymphoblastic Leukemia (ALL)
- Enrolled on SJLIFE
- Participant was less than 21 years of age at time of diagnosis
- Age 20-50 years at the time of enrollment
- Insomnia Severity Index >=8 (Proxy >=8) confirmed prior to enrollment
- Access to home Wi-Fi and Smartphone
- Participant is able to speak and understand the English language
- Participant is able and willing to give consent
Who cannot take part
- Currently taking medication intended to treat neurocognitive impairment (i.e. stimulants) or medications prescribed for seizure management
- Medications and behavioral practices (white noise, night-time yoga, etc) are acceptable as long as the insomnia is persistent
- History of skin irritation or other issues during stimulation of inner ear
- Currently utilizing a technological intervention for a sleep disorder (e.g. CPAP)
- History of a contraindicated health condition including:
- Cardiac dysrhythmia (CTCAE >2)
- Vascular Disease (CTCAE >2)
- Coronary Artery Disease (CTCAE >2)
- Active contraindicated heath condition including:
- Cranial Nerve Disorder (CTCAE >2)
- Cardiac tachycardia (CTCAE >2)
- Seizures (Any in most recent 1 year
- Unable to understand the details and requirements of the study (at the discretion of the PI)
- Female participants who are pregnant or planning to become pregnant
- Presence of implanted electrical medical devices (i.e. pacemaker)
- Syncope (CTCAE >2)
- Neuropathy (Cranial Nerves) (CTCAE >2)
- Neuralgia (Cranial Nerves) (CTCAE >2)
- Overt Cerebrovascular Accident (CTCAE >2)
- Currently enrolled or participating in any other neurostimulation or neuromodulation ancillary research studies
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 50 years old?
Where in United States
- St. Jude Children's Research HospitalMemphis, United StatesContact: Justin E Tanner, PhDTaking people
About the trial
What the trial wants to find out
This pilot study will assess the usefulness and potential effectiveness of using transcutaneous auricular vagus nerve stimulation (tVNS) for treating insomnia in adult survivors of childhood acute lymphoblastic leukemia (ALL). Participants will be randomized to receive either active (verum) or inactive (sham) nightly stimulation using a non-invasive earbud device over two time periods: 2 weeks and 8 weeks. The study will assess adherence to the intervention and estimate its effects on sleep quality, stress, and neurocognitive function.
Read full original descriptionShow less
Primary Objective:
Aim 1: To determine a) short-term and b) long-term feasibility of tVNS in terms of participation in ALL Survivors with moderate to severe insomnia.
Aim 2: To estimate the effect size of tVNS on sleep quality, stress, and neurocognitive outcomes in ALL survivors with insomnia.
Exploratory Objectives
Aim 1: To investigate the onset of tVNS effect via actigraphy measures over the intervention epoch.
Aim 2: To estimate the effect size of genetic variants on sleep quality within verum tVNS.
The 2 groups in the trial
- Verum tVNS (Active Treatment)Treatment being tested
Participants randomized to receive active transcutaneous auricular vagus nerve stimulation (tVNS) using the Soterix device. Stimulation is delivered nightly for 20 minutes at 80% of the participant's discomfort threshold.
Treatment: Soterix tVNS device, Sleep Quality, and Neurocognitive and mental health outcomes
- Sham tVNS (Placebo Comparator)Sham treatment, for comparison
Participants randomized to receive sham stimulation using the same Soterix device, but with no active electrical stimulation. The procedure mimics the verum condition in duration and setup.
Treatment: Soterix tVNS device (sham programmed), Sleep Quality, and Neurocognitive and mental health outcomes
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Feasibility and Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
- Plain-language title
- Ear Nerve Stimulation Device Tested for Sleep Problems in Childhood Leukemia SurvivorsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07191119, who can take part
- Record updated
- 14 August 2026